Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Xoma licenses protein production technology to Invitrogen for research use

April 29, 1998

Abgenix, Genentech form research collaboration

April 29, 1998

Theratechnologies and Genetix enter strategic alliance

April 28, 1998

Genometrix and GeneMedicine embark on high-throughput screening effort

April 27, 1998

ArQule and Acadia forge drug discovery collaboration

April 24, 1998

Targeted Genetics patents retroviral gene delivery system using chimeric proteins

April 24, 1998

GeneMedicine reports advances in muscle gene delivery systems

April 24, 1998

Alza licenses two drug delivery technologies to Alkermes

April 22, 1998

Sheffield signs option agreement with Zambon for MSI delivery system

April 21, 1998

Inhale licenses technology from Initiatech

April 17, 1998

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...